Health Professional Times
SEE OTHER BRANDS

Bringing you the latest news on healthcare and wellness

Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on July 8, 2025

Aesthetic Medicine Market Set to Surge at 10.7% CAGR, to Reach US$ 264.9 Billion by 2035: Fact.MR Report

Aesthetic Medicine Market Set to Surge at 10.7% CAGR, to Reach US$ 264.9 Billion by 2035: Fact.MR Report

Aesthetic Medicine Market to grow at 10.7% CAGR through 2035, driven by non-invasive procedures, tech innovation, and rising global beauty awareness. ROCKVILLE, MD, UNITED STATES, July 8, 2025 /⁨EINPresswire.com⁩/ -- A new research report published by …

Dr. Gordon Telford Inducted into the International Order of Fantastic Professionals

Dr. Gordon Telford Inducted into the International Order of Fantastic Professionals

Creator of Cloud Vitamin Creams receives Lifetime Achievement in Dermatologic Innovation Award EDMONTON, ALBERTA, CANADA, July 8, 2025 /⁨EINPresswire.com⁩/ -- Dr. Gordon Telford’s Dermatology practice was simple – help people feel healthy, safe, and …

Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 39 Mio. für die weitere Entwicklung der neuen Antipilzmittel Fosmanogepix und BAL2062

Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 39 Mio. für die weitere Entwicklung der neuen Antipilzmittel Fosmanogepix und BAL2062

Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 08. Juli 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patientinnen und Patienten zu helfen, die an schweren …

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service